Cardinal Health price target raised to $255 from $245 at Morgan Stanley

Group 1 - Morgan Stanley raised the price target on Cardinal Health (CAH) to $255 from $245 [1] - The firm maintains an Overweight rating on Cardinal Health shares [1] - The updated risk-reward profile follows the company's strong Q2 results [1]